Sulfonamide derivatives as chymase inhibitors

Details for Australian Patent Application No. 2008204583 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Wessel, Hans P.; Mauser, Harald; Minder, Rudolf E.; Banner, David

Agent Davies Collison Cave

Pub. Number AU-A-2008204583

PCT Pub. Number WO2008/084004

Priority 07100337.0 10.01.07 EP

Filing date 3 January 2008

Wipo publication date 17 July 2008

International Classifications

C07D 213/42 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4436 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 333/62 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/084004 Priority application(s): WO2008/084004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008204586-Use of a tailored recombinases for the treatment of retroviral infections

2008204566-Novel mesenchymal progenitor cells derived from human blastocyst-derived stem cells